GEMINI BIOPRODUCTS LLC

Gemini Bioproducts LLC specializes in the manufacturing and supply of high-purity biological products for research and therapeutic cell culture applications, with deep expertise in fetal bovine serum, xeno-free culture media, and associated reagents. The company delivers critical raw materials—including serum lots, antibiotics, and cell culture supplements—that support primary cell isolation, stem cell expansion, and biopharmaceutical development workflows. Their technical focus centers on consistent product quality, traceability, and compliance with Good Manufacturing Practices for biologicals, ensuring suitability for sensitive in vitro and preclinical applications. Differentiators include validated xeno-free formulations and lot-specific documentation critical for reproducible research and regulatory-grade cell production. The contractor maintains a sustained relationship with the Department of Health and Human Services, supplying essential cell culture components to laboratories engaged in biomedical research, vaccine development, and cellular therapy programs. Work performed consistently supports NIH-funded and OMBRELLO-affiliated research initiatives requiring certified biological reagents for cell line maintenance and expansion. The agency relies on Gemini for reliable, mission-critical consumables that meet stringent purity and sterility standards. Operating under NAICS 325414, Gemini Bioproducts is positioned as a niche supplier in the biological products manufacturing sector, specifically serving the life sciences and translational research markets. Their focus on serum-based and serum-free culture systems aligns with industry trends toward defined, animal-component-free environments for clinical-grade cell manufacturing. Gemini Bioproducts LLC is a small business entity headquartered in West Sacramento, California, with no federal certifications on record. The company’s geographic presence and operational focus are centered on supporting federal research infrastructure through precise, high-integrity biological supply chains, establishing itself as a trusted provider in the U.S. government’s life sciences ecosystem.